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c-myc is essential for cell homeostasis and growth but
lethal if improperly regulated. Transcription of this onco-
gene is governed by the counterbalancing forces of two
proteins on TFIIH—the FUSE binding protein (FBP) and
the FBP-interacting repressor (FIR). FBP and FIR recog-
nize single-stranded DNA upstream of the P1 promoter,
known as FUSE, and inﬂuence transcription by oppositely
regulating TFIIH at the promoter site. Size exclusion
chromatography coupled with light scattering reveals
that an FIR dimer binds one molecule of single-stranded
DNA. The crystal structure conﬁrms that FIR binds FUSE
as a dimer, and only the N-terminal RRM domain partici-
pates in nucleic acid recognition. Site-directed mutations
of conserved residues in the ﬁrst RRM domain reduce
FIR’s afﬁnity for FUSE, while analogous mutations in the
second RRM domain either destabilize the protein or have
no effect on DNA binding. Oppositely oriented DNA on
parallel binding sites of the FIR dimer results in spooling
of a single strand of bound DNA, and suggests a mechan-
ism for c-myc transcriptional control.
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Introduction
The biological repercussions of c-myc expression are far
reaching and determine cell fate. Disturbances in c-myc
regulation and function are frequent observations in human
malignancy (Dang et al, 1999), and the cellular targets of
MYC encompass many major biochemical and regulatory
processes in the cell (Fernandez et al, 2000; Orian et al,
2003). These observations imply that transcription of this
oncogene must be closely regulated. FUSE-binding protein
(FBP) binds to an AT-rich single-stranded DNA (ssDNA)
sequence upstream of the P1 promoter known as the Far
Upstream Element (FUSE). During transcription initiation,
FUSE melts due to torsional stress (Duncan et al, 1994) and
is recognized by FBP (Michelotti et al, 1996), a powerful
stimulator of the p89 helicase of transcription factor IIH
(TFIIH), thereby activating c-myc transcription (He et al,
2000). The nucleic acid-binding region of FBP is comprised
of four central K homology (KH) motifs, which recognize
melted FUSE. The three dimensional solution structure and
molecular dynamics of the third and fourth KH domains of
FBP bound to a 29 ssDNA sequence from FUSE determined
by NMR spectroscopy demonstrates that FBP binds FUSE in
an extended, linear protein–DNA complex in which the DNA
is in an extended B-form conformation (Braddock et al,2 0 0 1 ,
2002b).
Counterbalancing FBP’s effects on c-myc transcription is
the FBP-interacting repressor (FIR), which binds FBP, FUSE
and TFIIH, and returns c-myc transcription to basal levels (Liu
et al, 2000). FIR is a 542-amino-acid protein possessing a
central nucleic acid-binding domain comprised of two RRMs,
and an N-terminal domain that represses activated, but not
basal, c-myc transcription. In the presence of FBP, FIR is an
overriding negative regulator of c-myc (Liu et al, 2001),
functioning by neutralizing FBP’s stimulation of the p89/
XPB 30–50helicase of TFIIH by an as yet undescribed mechan-
ism. Mutants of TFIIH, defective in FIR binding, are seen in
the hereditary neoplastic syndrome xeroderma pigmentosum
(Liu et al, 2001, 2006). A splice variant of FIR within the
N-terminal repression domain was recently identiﬁed in
human colorectal cancers but not in adjacent normal tissue
(Matsushita et al, 2006), underscoring FIR’s role in c-myc
regulation. In addition to its role in gene regulation, splice
variants of FIR and its rat homologues have been implicated
in RNA-splicing reactions (Page-McCaw et al, 1999; Poleev
et al, 2000; Zhou et al, 2002), while the Drosophila homo-
logue, Half-Pint (HFP), which regulates Drosophila c-myc
expression and the cell cycle (Quinn et al, 2004), may also
regulate splicing of a subset of ovarian genes during devel-
opment (Van Buskirk and Schupbach, 2002).
Domain truncation experiments reveal that FIR interacts
with TFIIH via the N-terminal 55 amino acids (Liu et al,
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2772000), with FBP via two central RRM domains and with FUSE
via the same RRM domains (Chung et al, 2006). Although
both FBP and FIR bind FUSE, the degree to which they
compete for binding is not known. Previous studies identiﬁed
binding sequences on FUSE for the third and fourth KH
domains of FBP, but the exact FIR-binding sequences remain
unknown. In order to deﬁne FIR’s interactions with FUSE,
and as a prelude to understanding FIR’s activator-selective
repression of c-myc, we conducted biophysical and biochem-
ical experiments on the ﬁrst two RRM domains of FIR with 27
bases of FUSE (referred to as H27) and determined the
structure of this FIR construct bound to a 25-base sequence
of FUSE (H25).
Results
NMR analysis of the FIR:H27 complex
A 216-amino-acid protein (hereafter referred to as FIR1þ2)
consisting of the two central RRM domains of human FIR
(accession code AF217197), residues 101–299, preceded by a
His-tag, was expressed and puriﬁed for biochemical, biophy-
sical and crystallization experiments (see Materials and
methods). To evaluate the folding, stability and complex
formation of our samples, NMR experiments were performed
on FIR1þ2 in the presence and absence of a 27-nucleotide
ssDNA corresponding to c-myc  1561 to  1535 (Figure 1A);
this sequence was previously demonstrated to form a com-
plex with FIR1þ2, but the nucleotides involved in direct
interactions are unknown (H-J Chung and D Levens, unpub-
lished observation). Protein–DNA complexes were isolated
from unbound components, and
15N–
1H HSQC spectra were
acquired of the protein–ssDNA complex with and without
transverse optimized spectroscopy (TROSY) pulse sequences
(Supplementary Figure 1A). The increased signal to noise and
modest line width reduction with the use of TROSY suggested
that the FIR1þ2:H27 complex was larger than a 1:1 complex
(see Supplementary data). To determine if this was indeed the
case, we examined the oligomeric state of FIR1þ2 in the
presence and absence of H27 using size-exclusion chromato-
graphy (SEC) with light scattering (LS).
Oligomerization of FIR in solution
The oligomerization of FIR and its dependence on DNA
binding was determined using SEC coupled with LS, refrac-
tive index (RI) and absorbance (UV) detection (SEC-LS/RI/
UV). A series of SEC-LS/RI/UV measurements at various
loading concentrations of equimolar FIR1þ2 and H27, or
FIR1þ2 protein alone were collected. Although FIR1þ2
remains monomeric at concentrations up to 120mM, the
molecular weight (MW) of FIR1þ2:DNA complex reaches
58kDa at 111mM (Figure 1B), in agreement with an expected
MW of 55kDa for FIR1þ2:DNA complex of 2:1 stoichiome-
try. This stoichiometry was conﬁrmed by an online measure-
ment of extinction coefﬁcient for FIR1þ2:DNA complex
(Wen et al, 1996). Namely, to differentiate between 2:1 and
2:2 stoichiometry, with MWof 55 and 64kDa respectively, we
used the (UV)/(RI) ratio, which is directly proportional to the
weight-extinction coefﬁcient, A295
0.1% (ml/mgcm), for the ab-
sorbance at 295nm of a 1mg/ml solution at a 1-cm path
length (Wen et al, 1996). Because the observed UV/RI ratio
for the DNA fragment used is 18 times higher than that of
FIR1þ2, the FIR1þ2:H27 complex with 2:2 stoichiometry
would produce a UV/RI ratio 1.5 times higher than a complex
with 2:1 stoichiometry. The observed UV/RI ratio for
FIR:DNA complex at the highest concentration tested is
consistent with the absorbance expected for the 2:1 stoichio-
metry. Interestingly, at an FIR1þ2:H27 concentration of 4mM
the weight-average MW of the complex decreases to 30kDa
and the UV/RI ratio increase B2-fold, suggesting that the
FIR:DNA dissociation produces a 1:1 FIR:DNA complex as
an intermediate in the FIR dimerization induced by DNA
binding.
The FIR1þ2:H27 complex was stable and well ordered in
solution as evaluated by NMR, but ill-suited for full structure
determination by standard multidimensional NMR techni-
ques due to size limitations, revealed in the NMR and LS
experiments. Therefore, structure determination proceeded
with X-ray crystallography.
A structurally unique dimer interface
Crystals of the FIR1þ2 protein complexed to ssDNA were
grown and optimized by shortening the DNA strand two
nucleotides (to H25, Figure 1A) to decrease crystal mosaicity.
FIR1þ2:H25 crystals diffracted to 2.1A ˚, belonged to space
group P31, and contained two protein molecules and
one DNA strand per asymmetric unit. Selenomethionine
protein:DNA complex crystals were prepared and a multi-
ple-wavelength anomalous dispersion (MAD) data set was
collected at the National Synchrotron Light Source at
Brookhaven National Laboratory. The structure was solved
to 2.6A ˚ with the MAD data and reﬁned to 2.1A ˚ against the
native data to an R¼25.8%/Rfree¼29.5%. Additional crystallo-
graphic statistics are presented in Table I.
The overview of the FIR RRM1þ2:H25 structure is shown
in Figure 2. The protein binds DNA as a dimer in which only
the N-terminal RRM domain of each subunit interacts with
ssDNA. The protein monomers are packed head to head and
rotated 1801 about their long axes such that the nucleic acid-
binding domains of the symmetry-related chains face in
opposite directions. The protein binds ssDNA as a dimer
with a unique subunit interface and buries 1169A ˚ 2 of pair-
wise surface area. The rotation about the twofold axis
juxtaposes identical RRM secondary structural elements at
the dimer interface so that the RRM1 domains contact each
other at their fourth b-strand and in the loop between the
second a-helix and the fourth b-strand, while the C-terminal
RRM domains (RRM2) form dimer contacts at their second
a-helices. The dimerization interface between the b-strands
in RRM1 are antiparallel to one another, while the dimeriza-
tion contacts between the a-helices in RRM2 cross each other
at about a 1351 angle with respect to their long axes.
The dimer interface is stabilized by a moderate number of
hydrogen bonds (Figure 3). In the C-terminal RRM domain,
hydrogen bonds are formed between the side chain amide of
Gln264 and both the main-chain oxygen and side-chain
hydroxyl of Ser268 of the other subunit (Figure 3A). The
two N-terminal RRM domains form an intricate network of
hydrogen bonds (Figure 3B) involving the side chains of
Asn174 (both subunits) and Lys184 (one subunit) and main
chain atoms of Val185 (both subunits).
Although there are eight hydrogen bonds between the
dimer interface, the complementarity among the monomer
surfaces is not ideal. We performed a sequence alignment
with all other RRM domains that bind nucleic acids whose
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sesses all four residues having side chains involved in
hydrogen bonds across the interface and that another RRM
protein, HuD, has two of these four residues (Figure 4A).
Similar to FIR, both of these contain two tandem RRM
domains. However, both sex-lethal and HuD are monomers
in the presence of nucleic acid. To investigate the structural
basis of the difference in oligomeric state between FIR and
the sex-lethal and HuD structures, we superimposed the Cas
of the RRM1 domains of FIR and sex-lethal and found a
different orientation and location for the RRM2 domains
(Figure 4B). (Superposition of the Cas of the RRM1 domains
of FIR and HuD is similar to that of sex-lethal). We analyzed
the structure and sequences of FIR, sex-lethal and HuD to
ﬁnd what leads to the dramatic differences in domain topol-
ogy within the subunits and the dimerization of FIR. We
found one major difference between the FIR1þ2 and the two
other proteins. The linker between RRM1 and RRM2 in FIR is
a long a-helix (Figure 4) relative to the short linkers in sex-
lethal and HuD, which have no speciﬁc secondary structure.
The linker a-helix of FIR1þ2 interacts with a long N-terminal
a-helix, resulting in a totally different positioning of the
second RRM domain, allowing for a long, relatively ﬂat
dimer-forming surface, which is absent in sex-lethal and
HuD. This surface has a weak propensity to form a dimer,
and the interaction of two protein monomers with a single
strand of DNA increases the local concentration of the protein
such that dimerization occurs.
RRM domain packing in the monomer subunit
The C-terminal RRM domain of FIR1þ2 interacts extensively
with the N-terminal domain, burying a pairwise accessible
surface area of about 2000A ˚ 2, the most observed in a dual
RRM domain protein structure (Figure 5A and B) and about
double that buried in other multi-RRM domain proteins
involved in domain interactions (Maris et al, 2005; Vitali
et al, 2006; Bae et al, 2007). Residues in the second RRM
domain of FIR predicted to participate in nucleic acid binding
are instead involved in interdomain contacts with RRM1.
Many of these interactions are hydrophobic: Tyr212 with the
Figure 1 Sequence and solution characterization of FIR1þ2:FUSE complex (A) Sequence of protein and DNA constructs used in this study.
The sequence and secondary structure of FIR1þ2 corresponding to human FIR residues 101–299 is shown. The corresponding sequences of
PUF60 and Siah-BPare identical to FIR RRM1þ2. The RRM domains are colored in red, and residues mutated from Cys are colored in blue. The
sequence of each RNP1 is boxed, and the sequence of each RNP2 is underlined in each RRM domain. (B) Oligomeric state of FIR–DNA complex
from SEC-UV/LS/RI analysis. Weight-average MWs determined from SEC-UV/LS/RI analyses are plotted as ﬁlled triangles for FIR–DNA
complex and open triangles for FIR protein alone. Averages and standard deviations were calculated from 25 MW determinations for the top
0.2ml of the eluting peaks for which the concentration is within 5% of the plotted value.
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Val162 (Figure 5C). The packing of the RRM domains is also
stabilized by a network of interdomain salt bridges and
hydrogen bonds. A salt bridge between Glu161 and Lys250
contributes to this network between the two domains. The
putative RRM2 DNA-binding residue Tyr212 forms a hydro-
gen bond with the backbone carbonyl of Phe135 and the
backbone carbonyl of Pro134 hydrogen bonds with the side-
chain hydroxyl of Ser215. The side chain of Gln172 forms two
hydrogen bonds: one between the amide group to the side-
chain carbonyl of Asn271 and the other between the carbonyl
of Gln172 to the guanidine moiety of Arg281.
FIR1þ2:FUSE binding analyzed by ﬂuorescence
anisotropy
Such extensive interactions between the two RRM domains is
unprecedented among all known RRM domains containing
consensus aromatic residues critical for nucleic acid binding
within their two short RNP motifs (Figure 1). To evaluate
the participation of RNP sub motifs in FIR1þ2 binding, we
mutated conserved aromatic residues to leucine. This sub-
stitution retains the hydrophobic character of the amino-acid
side chain but eliminates p bonding interactions with stacked
nucleic acid bases, and therefore is expected to decrease
afﬁnity of the protein for nucleic acid if the RNP motif
binds nucleic acid.
Alteration of aromatic residues in either RNP motif of
RRM1 dramatically affected FUSE binding as determined by
ﬂuorescence anisotropy. In accordance with the SEC results,
we ﬁt the ﬂuorescence anisotropy data to a model in which
two molecules of FIR bind sequentially to two distinct bind-
ing sites on FUSE. Wildtype FIR1þ2 binds H27 to the ﬁrst
site with a Kd1 of 2.371.8mM (Figure 6) and to the second site
with a Kd2 of 74747mM, both of which are within the range
of reported afﬁnities of individual RRM domains for nucleic
acid (10
 4–10
 6M) (Zamore et al, 1992; Amrute et al, 1994;
Shamoo et al, 1994; Conte et al, 2000). Mutating Tyr115 in the
second RNP motif of RRM1 to Leu reduced the afﬁnity for
both sites by a factor of 40 and 5–81731 and 3807110 mM,
respectively, while mutating a conserved residue in the ﬁrst
RNP motif of RRM1, Phe157, to Leu also reduced binding by
70- and seven-fold to 140785 and 4907310 mM, essentially
abrogating speciﬁc FIR-FUSE interaction (Table II).
Analogous mutations in the second RRM domain disrupted
protein folding, resulting in either insoluble protein that
could not be refolded or protein that was stable only within
a limited concentration range compared with wildtype. These
observations are consistent with our structure, which reveals
that the nucleic acid-binding surface of RRM2 is essentially
buried in a hydrophobic pocket formed between the two
RRM domains (Figure 5). In agreement with this packing
arrangement, we found that the protein was intolerant to
changes in the completely buried Y212 residue. Mutating the
partially buried Phe254 residue was better tolerated
and yielded enough metastable protein to perform a limited
binding study by ﬂuorescence anisotropy (Figure 6). While
we were unable to obtain sufﬁcient quantities of this protein
to produce a saturating binding curve, the results up to
B25mM protein clearly show that F254L retains high
afﬁnities (Kd1, 0.1770.13mM; Kd2,2 0 76.7mM) for FUSE,
thus conﬁrming that RRM2 of FIR is uninvolved in nucleic
acid binding.
Table I Crystallographic statistics
MAD data
Wavelength (A ˚) 0.9794 0.9798 0.9600
Unique reﬂ. (total reﬂ.) 22625 (126675) 22692 (128330) 22908 (128321)
Resolution (A ˚) (highest shell) 50–2.6 (2.69–2.6) 50–2.6 (2.69–2.6) 50–2.6 (2.69–2.6)
Rsym (highest shell) 0.068 (0.284) 0.069 (0.272) 0.067 (0.410)
/IS//sS (highest shell) 18.4 (4.5) 17.4 (4.8) 18.8 (3.8)
Completeness, % (highest shell) 98.4 (99.6) 99.4 (100.0) 99.6 (100.0)
Mean ﬁgure of merit
Before density modiﬁcation 0.561
After density modiﬁcation 0.715
Native data
Wavelength (A ˚) 1.1000
Unique reﬂ. (total reﬂ.) 20889 (106953)
Resolution (A ˚) (highest shell) 50–2.1 (2.18–2.1)
Rsym (highest shell) 0.059 (0.370)
/IS//sS (highest shell) 21.8 (2.26)
Completeness, % (highest shell) 97.5 (92.2)
Reﬁnement
Space group P31
Unit cell a¼b¼63.135A ˚, c¼82.589A ˚, a¼b¼901, g¼1201
Resolution (A ˚) 2.1
Rwork/Rfree 25.8/29.5%
r.m.s.d. bond lengths (A ˚) 0.012
r.m.s.d. bond angles (deg) 1.9
Average B-factors (A ˚ 2)
Total 54.588
Protein 54.073
DNA 92.251
Water 53.418
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The crystal structure reveals that only the N-terminal RRM
domains participate in nucleic acid recognition. Although
only a single base can be modeled with certainty in each
binding site, this is sufﬁcient to deﬁne the directionality of
binding due to the orientation of the deoxyribose rings. In
agreement with other known RRM–nucleic acid complexes,
the DNA is bound to the RRM b-sheet, with the 50 end located
on the ﬁrst half (b4b1) of the sheet and the 30 end on the
second half (b3b2) (Figure 7A). The nucleic acid orientation
in all RRM domains is conserved, so the dimerization of
FIR1þ2 oppositely orients the DNA on parallel binding sites
of the FIR monomers such that direct threading of ssDNA
between the neighboring nucleic acid-binding sites is impos-
sible without looping the DNA.
The base recognition of FUSE by FIR is structurally similar
to recognized nucleic acid interaction by RRM domains. The
RRM consensus sequence of FIR in the N-terminal RRM
domain (RRM1) is K-G-F-A-F-V-E-Y (RNP1) and V-Y-V-G-S-I
(RNP2). Hydrophobic base stacking interactions between the
aromatic ring of Tyr115 (in the second position of RNP2) and
DNA are clearly present at the binding site in each subunit
(Figure 7B–D). This interaction is typically found in nucleic
acid–RRM domain complexes, along with base stacking of the
next nucleotide with the ﬁfth residue of RNP1, which is
Phe157 in RRM1. Tyr115 base-stacks with Cyt-2 in one
subunit and an adenine in the other subunit (Figure 7B and
C). This observation agrees with a recent analysis of base
recognition by RRM domains, which concludes that a C or A
is better accommodated in the RNP2 pocket of the RRM
domain (Auweter et al, 2006). Electron density is seen both
30 and 50 to each of these bases and electron density corre-
sponding to nucleotide bases stacking with Phe157 of each
subunit are present, but the quality is insufﬁcient to reliably
model the bases (Figure 7D). However, the nucleotide se-
quence of H25 has a single CG repeat and three AT repeats,
and therefore the FIR dimer binds the sequence CGyAT. The
asymmetry of the oligonucleotides in the RRM-binding pock-
et suggests that a single DNA molecule is bound by an FIR
dimer, which is supported by the solvent fraction calculated
from a crystal containing either one or two DNA molecules. If
an FIR dimer and one molecule of DNA is used in the
calculation, the solvent fraction of the crystals is 35%,
whereas if two molecules of DNA and a dimer of FIR is
Figure 2 Structure of FIR1þ2 bound to FUSE DNA. (A) Ribbon representation showing the domain organization. RRM domains 1 and 2 of
subunit A are in red and magenta, respectively. RRM domains 1 and 2 of subunit B are in blue and cyan, respectively. DNA is shown in purple.
Residues 147–150 and 179 of subunit A, where electron density is poor, are not included in the ﬁgure. The view on the right is rotated 901 from
that on the left. The two-fold axis relating the two subunits is in the plane of the page in both views. (B) Stereo-view of 1.0s2Fo–Fc electron
density of a portion of the protein from the b1-strand of RRM2 (subunit B). This ﬁgure and parts of Figure 7 were prepared using Molscript and
Bobscript (Kraulis, 1991; Merritt and Bacon, 1997).
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the crystal volume occupied by solvent in all protein crystals
ranges from 78 to 27%, with a rather sharp cutoff at the lower
end corresponding to the approximate value for closely
packed spheres (Kantardjieff and Rupp, 2003). As protein–
DNA crystals with solvent contents lower than 27% are
nonexistent, the asymmetric unit almost certainly consists
of a single DNA and two FIR molecules. Therefore, the bound
adenine and cytosine are interpreted as part of the same
oligonucleotide chain. Ade-6 is too close to Gua-3 to allow a
single strand to loop across the dimer, but either Ade-13 or
Ade-23 is a possibility.
In classical RRM binding, hydrophobic interactions be-
tween the aromatic residue at position 3 of RNP1 and the
sugar between the dinucleotides are present. In the FIR:FUSE
structure this residue (Phe155) packs near this sugar, against
the C50 atom of Cyt-2s DNA backbone, but not to the sugar
ring as typically described. Base recognition of the adenine is
provided by the main-chain oxygen of Arg187, which accepts
a hydrogen bond from the 6-amino group on the adenine ring
(Figure 7E). This helped us identify this residue as an adenine
as opposed to a guanine, which contains a carbonyl
at position 6. The main-chain amide of Ser189, located just
C-terminal to the ﬁnal b4 strand and therefore outside the RRM
domain, may form a weak hydrogen bond with the N7 atom of
the adenine. The side chain of Ser189 in the other subunit
donates a hydrogen bond to the O2 atom of the cytosine.
Discussion
Nucleic acid recognition by FIR
The nucleic acid-binding region of FIR is comprised of two
centrally located RRM domains. RRM domains are typically
present as multiple copies in nucleic acid-binding proteins,
with each RRM domain contributing to the avidity and
speciﬁcity of the protein for nucleic acid. The arrangement
of the RRM domains in the crystal structure of the
FIR1þ2:H25 complex is surprising because the C-terminal
RRM domain does not participate in nucleic acid recognition.
Indeed, FIR is the only example of a multi-RRM protein in
which one RRM domain participates in nucleic acid bind-
ing while the other RRM domain is sequestered in protein
contacts.
To validate the nucleic acid binding observed in the crystal
structure, we tested the effect of site directed mutations in the
DNA-binding region of each RRM. Mutations were chosen to
eliminate p stacking interactions between aromatic residues
in the protein and DNA, an established mechanism of RRM
nucleic acid recognition. Site-directed mutants of the nucleic
acid-binding surface of RRM1, which is exposed to solvent
(Figure 5A), resulted in severely diminished nucleic acid-
binding. Analogous mutations in the second RRM domain
resulted in poorly soluble protein, consistent with the struc-
ture, which indicates that these residues are involved in
obligate interdomain protein–protein interactions necessary
Figure 3 Intersubunit interactions in the FIR–HJ25 complex. (A) The intersubunit interactions involving the RRM2 domains are shown (right)
looking toward the surface in the direction of the arrow in the left panel. (B) Hydrogen bonding network involving RRM1 in the subunit
interface, showing the participation of Asn 174 and Lys 184. The orientation is with the DNA-binding region toward the top. This ﬁgure was
prepared using Molscript.
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sufﬁciently stable to be analyzed for nucleic acid binding.
The afﬁnity between this mutant, F254L, and DNA was
unaltered (Figure 6), demonstrating that the hydrophobic
residues of RRM2 are important for the correct folding and
stability of FIR but not for nucleic acid recognition.
Figure 4 Comparison of FIR with monomeric tandem RRM domain proteins. (A) Sequence alignment showing the RRM domains in FIR1þ2
and the corresponding amino acids in the D. melanogaster protein sex-lethal and in the human HuD antigen (also known as ELAV-like protein 4).
Highlighted in purple are the RNP1 and two central nucleic –acid-interacting residues of RRM1, and in cyan those of RRM2. In gray are the
residues corresponding to those in FIR that form hydrogen bonds across the subunit interface. In pink is the linker region between the two RRM
domains. (B) Structural overlay of Drosophila sex-lethal (PDB entry 1B7F) on the FIR1þ2 dimer. The overlay was performed by least-squares
superposition of a-carbons in the ﬁrst RRM domain of sex-lethal onto the corresponding a-carbons of the ﬁrst RRM domain of a subunit of FIR.
The nucleic acid from both structures is omitted for clarity. This, as well as Figures 5 and 7C, was prepared using PyMol (DeLano, 2002).
Figure 5 RRM–interdomain contacts. (A, B). Surface representations of FIR1þ2 contrasting the surface exposure of DNA-recognition residues
of the N-terminal RRM domain (RRM 1) to the relative inaccessibility of corresponding residues of RRM 2. In panel A, Tyr115 (yellow) and
Phe157 (orange) are both solvent exposed. In panel B, Tyr212 (green) is completely buried and inaccessible to solvent, and Phe254 (purple) is
mostly buried. (C) Cartoon and stick representation of the hydrophobic interactions between the two domains. Aromatic residues in the
putative nucleic acid-binding site of RRM2 are involved in interdomain hydrophobic contacts. The RRM1 domain is colored blue, and the RRM2
domain is colored cyan, as in Figure 2.
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surfaces
Single RRM domains generally bind nucleic acid with afﬁ-
nities in the 10
 4–10
 6M range, while proteins with multiple
RRM domains display afﬁnities much greater (for review see
Maris et al, 2005). The exception to this rule is single RRM
domains, which bind nucleic acid with hairpin-like struc-
tures, which can exhibit very high (nM) afﬁnity (Rimmele
and Belasco, 1998; Law et al, 2006; Skrisovska et al, 2007).
While one would be tempted to assume that the afﬁnity of a
multi-RRM domain protein would be the product of the
individual afﬁnities, this turns out to be incorrect. The
afﬁnity of combined RRM domains has been experimentally
linked to the length of the ﬂexible linker separating the
domains—the shorter the linker, the greater the afﬁnity
(Shamoo et al, 1995). A mathematical relationship between
linker length and ligand afﬁnity has been derived, which
allows one to predict the afﬁnity of a dual RRM domain
protein given the afﬁnity of the individual domains:
K
0
2 ¼ 3VðK2Þ=4pðr3ÞN
where K2
0 is the afﬁnity that would be observed for a second
RRM domain had it bound ﬁrst, r is the mean free
radius linking the two RRM domains and N is the number
of protein molecules per volume V. According to this model, a
dual RRM domain protein with a linker length of 20 residues
and an individual Kd of 10
 5M should bind nucleic acid
with a dissociation constant of 120nM, or over an order of
magnitude greater than observed for the FIR1þ2-FUSE
complex. This observation is also consistent with the notion
that only a single RRM domain of FIR1þ2 is involved in
DNA recognition.
In addition to RNA-bound sex-lethal (Handa et al, 1999)
and HuD (Wang and Tanaka Hall, 2001), ﬁve other structures
of tandem RRM proteins bound to nucleic acids have been
determined: hnRNP A1 complexed with telomeric ssDNA
(Ding et al, 1999), nucleolin bound to an RNA stem loop
(Allain et al, 2000), poly(A)-binding protein (PABP) bound to
polyadenylate RNA (Deo et al, 1999), all four domains of
polypyrimidine tract-binding protein (PTB) complexed with
RNA (Oberstrass et al, 2005) and U2AF with a polypyrimidine
tract (Sickmier et al, 2006). These complexes can be grouped
into two classes—those whose RRM domains closely contact
each other to bind nucleic acid and those that do not.
The ﬁrst two RRM domains of PTB, the RRM domains of
nucleolin, sex-lethal, HuD and U2AF all bind nucleic acid
as independent modules, while the RRM domains of
hnRNPA1, PABP and the third and fourth domains of PTB
all form interdomain contacts when bound to RNA. Multi-
RRM domain proteins that form intersubunit or oligomeric
contacts usually do so to extend their nucleic acid-binding
surfaces. The RRM domains of hnRNPA1 bound to telomeric
DNA, for example, pack in a head to tail arrangement that
extends a 50–30 nucleic acid polarity across both RRM do-
mains, allowing for continuous binding of ssDNA between
subunits. In PABP, the RRM domains of a single subunit
associate to form an extended b-platform capable of binding
an elongated, contiguous nucleic acid. In PABP, the RRM
domains interact burying 550A ˚ 2 of surface area to form a
narrow binding trough capable of directly threading nucleic
acid from the second RRM domain into the ﬁrst. The third
and fourth RRM domains in the PTB–RNA complex depart
from this model. In this structure, the two RRM domains of a
subunit associate along their dorsal (a-helical) surfaces,
causing their b-sheet surfaces to face in opposite directions
from each other such that these contiguous domains are
incapable of binding a single extended nucleic acid sequence
without looping. Although the dimer interface of FIR is
different than that used by the third and fourth domains of
PTB, the effect is the same: a single bound oligonucleotide
must be looped or spooled to bind two RRM domains.
Models for FIR inhibition of c-myc
c-myc is a lethal oncogene if improperly regulated, yet
essential for life. Cells with MYC haploinsufﬁciency double
more slowly than their parent cells, while complete loss of
MYC expression in somatic cells severely hampers prolifera-
tion (Mateyak et al, 1997). c-myc knockout mice expire at
embryonic day 10.5 (Davis et al, 1993), and MYC haploin-
sufﬁcient mice are viable but grow more slowly and are
smaller than their wildtype siblings (Trumpp et al, 2001).
Figure 6 Equilibrium binding afﬁnities of wildtype and mutant FIR
determined by ﬂuorescence anisotropy. Steady-state anisotropy of
30-ﬂuorescein-labeled H27 is plotted as a function of FIR concentra-
tion for FIR1þ2 wildtype (black squares), Y115L (red circles),
F157L (green triangles) and F254L (blue upside-down triangles).
Lines depict the best ﬁts of [FIR] dependence of the anisotropy data
to equation 3. The equilibrium binding afﬁnities obtained from the
best ﬁts of [FIR] dependence of the anisotropy data to equation 3
are presented in Table II.
Table II Afﬁnities of WTand mutant FIR1+2 to HH27
FIR r0 Kd1 r1 Kd2 r2
WT 0.03470.002 2.371.8 0.06570.012 74747 0.1270.01
Y115L 81731 * 3807110 *
F157L 140785 * 4907310 *
F254L 0.1770.13 * 2076.7 *
*Indicates that mutant data were ﬁt by constraining the r0, r1, and r2 values to those of wild type FIR.
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scarce, cellular apoptosis increases (Evan et al, 1992). MYC
misregulation alters cell proliferation, cell growth, cell differ-
entiation and cell metabolism, and MYC is a well recognized
molecular lesion in multistep carcinogenesis (for review see
Dang et al, 1999). The targets of MYC expression include
representatives of virtually every biochemical and regulatory
pathway in the cell (Menssen and Hermeking, 2002), demon-
strating the protein’s global importance to organismal fate.
All of these observations suggest that there are severe and
unforgiving consequences to MYC misregulation.
FBP and FIR are dominant regulators of Myc expression:
FBP is potent activator of myc, while FIR returns FBP
stimulated myc to basal levels. The following details of c-
myc regulation by FBP, FIR and FUSE have been established:
FUSE becomes single stranded due to forces generated during
c-myc transcription and transcription stalls; FBP binds to
single-stranded FUSE and TFIIH, allowing transcription to
proceed; and sometime later, FIR binds to FBP, FUSE and
TFIIH, reducing c-myc transcription back to basal levels (Liu
et al, 2006). The structure of the FIR:FUSE complex reveals
that FIR binds FUSE as a dimer, which spools a single bound
DNA strand. Analytical LS experiments demonstrate FIR to
be a monomer in the absence of DNA and a dimer at
higher protein concentrations in the presence of ssDNA.
Furthermore, UV/RI ratios reveal that FIR binds DNA with a
stoichiometry of 2:1 FIR:FUSE at high concentrations and of
1:1 at lower concentrations. Finally, the asymmetry of the
oligonucleotides in the dimeric RRM-binding pockets—one
being an ATand the other a CG—also supports the notion that
an FIR dimer binds a single strand of DNA in solution. These
observations allow us to propose that FIR binds FUSE as a
monomer, and then dimerizes as local protein concentrations
increase. The dimerization of FIR loops FUSE, inducing
a structural reorganization of upstream c-myc effector
elements, which favors a reduction of c-myc expression
to basal levels.
The structural model presented in Figure 8 is supported by
several in vitro and in vivo observations of FBP:FIR:FUSE
systems. FIR was discovered because of its ability to interact
with FBP (Liu et al, 2000) and the proteins have been
demonstrated to interact in vivo (He et al, 2003). Moreover,
ChIP analysis shows that FBP and FIR clearly coreside
at FUSE in vivo (Liu et al, 2006), and both proteins may be
Figure 7 (A) Nucleotide stacked against Tyr115 in subunit B, with 1.0s2Fo–Fc electron density, calculated by omitting the DNA from the
model. (B) 2.5sFo–Fc electron density, calculated by omitting the DNA from the model. The adenine stacking against Tyr115 in subunit A is
shown. (C) A view of the DNA-binding site centered on the dimeric interface, showing the base stacking of Tyr115 of each subunit with
nucleotide. Subunit A is depicted in maroon and subunit B in blue, similar to Figure 2A. (D) View of unmodelled 1.0s2Fo–Fc electron density
corresponding to DNA near Phe157. Shown is subunit B, but unmodelled density is also present in subunit A. (E) Hydrogen bond between
adenine and Arg187.
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binding and FBP ejection are noted to be temporally linked
(Liu et al, 2006). Finally, the biophysical and biochemical
experiments presented in this study demonstrate that FIR and
FBP bind FUSE in different conformational states of DNA.
Structural deformations of DNA induced during transcrip-
tion provide an immediate feedback mechanism for monitor-
ing gene transcription. The conformation of FUSE observed in
the repressor FIR:FUSE complex is quite different than in the
activator FBP:FUSE complex. The altered DNA conformation
suggests that structural changes in FUSE induced by FIR may
play a role in the activator-selective inhibition of c-myc.
Previous structures of FBP bound to FUSE reveal a ﬂexible,
linear protein–DNA complex (Braddock et al, 2002a). The
FIR:FUSE structure reveals that FIR alters the linear arrange-
ment of the DNA seen in the FBP:FUSE complex, and there-
fore conformational changes induced in FUSE by FIR
dimerization, may provide leverage to dissociate FBP’s
C-terminal activation domain from TFIIH, allowing FIR
to substitute its N-terminal repression domain on TFIIH
(Figure 8). Finally, dimerization of FIR bound to FUSE may
provide a locking mechanism stabilizing long-lived FIR:FUSE
complexes, which have been reported in time-course CHIP
assays (Liu et al, 2006). In a related manner, alternative
splicing products and homologues of FIR implicated in RNA
splicing, SIAH-BPI and HFP, may utilize dimerization to loop
out RNA excised in splicing reaction, as these factors bring
distant nucleotides into close proximity for splicing and
processing. This mechanism has been proposed for the loop-
ing of RNA induced by the third and fourth domains of PTB
(Oberstrass et al, 2005). Future structures of FBP:FIR and
FBP:FIR:FUSE complexes will provide further insight into this
unique means of genetic regulation.
Materials and methods
Cloning and protein expression and puriﬁcation, complex
formation
Nucleotides 311–907 from human FIR cDNA (GenBank accession
code AF217197), which correspond to human FIR amino acids 101–
299, were cloned into the pET15b protein expression vector with
an R to G mutation at amino acid 106. To ease protein handling,
cysteine residues in the sequence were replaced by serine (Cys112)
and alanine (Cys238) depending on their predicted location in the
protein structure (alanine if buried, serine if exposed). Cloning
artifacts introduced 17 amino acids at the N-terminus of the protein
following cleavage of a histidine tag, of which most are disordered
and only one is visible in the ﬁnal electron density. The protein was
expressed in Escherichia coli, strain BL21 (DE3), using standard
methods. Further details are provided in Supplementary data.
Synthetic oligonucleotides were purchased from The Midland
Certiﬁed Reagent Company (Midland, TX). The sequence of the
oligonucleotides corresponds to the FUSE element in human
c-myc  1561 to  1535 (H27, Figure 1A). H25 was used for
structural studies and is identical to H27 but lacks the two terminal
30 bases (Figure 1). FIR:DNA complexes were formed by mixing
the protein and DNA at a 1:1.1 molar ratio, and removing
uncomplexed material by gel ﬁltration on a Superdex S 75 column
Figure 8 Model of progression in FBP and FIR interaction with FUSE during c-myc transcription. FUSE becomes single stranded upon the
initiation of c-myc transcription and is recognized by FBP. Shortly thereafter, FIR binds the FBP/FUSE complex, forming a trimeric complex.
Finally, FBP is ejected and FIR forms a long-lived stable complex with FUSE. (A) Molecular dynamic studies of the third and fourth KH domains
of FBP bound to FUSE show that FBP binds FUSE as an elongated molecule in which the DNA is ﬂexible but linear (from Braddock et al,
2002a). (B, C) SEC/LS/RI/UV measurements demonstrate that FIR binds FUSE as a monomer at low concentrations, but dimerizes at higher
concentrations in the presence of ssDNA. FIR dimerization would change the topology of FUSE, helping to pry the C-terminal activation
domain of FBP of TFIIH and facilitate the ejecting FBP from FUSE.
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NaCL, pH 8.0.
Size exclusion and light scattering
The LS data were collected using a Superdex S-200, 10/30, HR SEC
column (GE Healthcare, Piscataway, NJ), connected to an HPLC
system, Alliance 2965, (Waters Corp., Milford, MA) equipped with
an autosampler. The elution from SEC was monitored by a
photodiode array (PDA) UV/VIS detector (996 PDA; Waters Corp.),
differential refractometer (OPTI-Lab, or OPTI-rEx Wyatt Corp.,
Santa Barbara, CA) and static, multiangle laser LS detector (DAWN-
EOS; Wyatt Corp., Santa Barbara, CA). The SEC-UV/LS/RI system
was equilibrated in 20mM HEPES, pH 8.0, 150mM NaCl, 1mM
EDTA buffer at the ﬂow rate of 0.5ml/min. The MW determination
in SEC-UV/LS/RI measurement depends only on the signals from
downstream LS and RI detectors (Folta-Stogniew and Williams,
1999; details presented in Supplementary data), and is independent
of the elution position; SEC is used solely as a fractionation step to
separate various oligomers or complexes. Thus, unusual elution
because of non-globular shape or interactions with the SEC support
has no impact on the MW determination by SEC-UV/LS/RI (Folta-
Stogniew and Williams, 1999). Further details regarding the
conversion of LS to concentration and weight average MWs,
relationship of the refractive index to the molar mass of the
complex, and other details are described in the Supplementary data.
Fluorescence anisotropy
Binding of wildtype and mutant FIR RRM1þ2 to FUSE DNA
was monitored by a change in the steady-state anisotropy of a 30
ﬂuorescein-labeled 27-mer sequence from the 30 end of FUSE
previously demonstrated to interact with FIR (sequence:
50CCTCGGGATTTTTTATTTTGTGTTATT-30), hereafter referred to as
H27. Experiments conducted with the ﬂuorescent probe at the 50
end of the oligonucleotide yielded identical results (not shown).
The concentration of DNA was kept constant at 50nM, while the
concentration of protein was varied from 0 to B400mM. Samples
were prepared in a buffer of 50mM Tris–HCl, 150mM NaCl, 20mM
EDTA, pH 8.0 and equilibrated at room temperature for at least
30min before measurements were taken on a two-channel
ﬂuorometer (Photon Technology International Alphascan, Birming-
ham, NJ). Excitation was at 485nm and emission was collected at
530nm with 4-nm slit widths. Further details regarding the
anisotropy measurements are available in the Supplementary data.
Crystallization and X-ray data collection
Crystals of the FIR1þ2:H25 complex grew from hanging drops of
0.1M Tris–HCl, 32% PEG 4000, pH 8.5 at room temperature in 7
days after the protein solution (20mg/ml, 20mM Tris–HCl, pH 8.0,
100mM NaCl) was mixed with an equal volume of the reservoir
solution. MAD and native data were collected at Brookhaven
National Light Source Beam X25. The crystals were ﬂash frozen in
liquid nitrogen without cryoprotection, mounted directly onto the
beamline, and annealed prior to data collection by interrupting the
stream of nitrogen for 3s. All three MAD data sets (peak, inﬂection
and remote wavelength) were collected from one crystal at 100K.
Each data set has 120 frames with an oscillation angle of 1.5 degree.
All data sets were processed using HKL2000 (Otwinowski and
Minor, 1997).
Solvent fraction calculation
The solvent content was calculated from the Mathews coefﬁcient
using the partial speciﬁc volume of the separate protein and DNA
constituents according to the method of Matthews as modiﬁed by
Kantardjieff and Rupp (Matthews, 1968; Kantardjieff and Rupp,
2003).
Structure determination and sequence alignment
SOLVE (Terwilliger and Berendzen, 1999) was employed directly on
the processed MAD data from HKL2000, and successfully found 10
selenium sites. RESOLVE (Terwilliger, 1999) was subsequently
employed for solvent modiﬁcation and NCS identiﬁcation. RE-
SOLVE unambiguously found a twofold axis and the resulting
electron density map at 3.0A ˚ clearly revealed protein structural
features so that b-strands and a-helices could be virtually identiﬁed.
The program Arp/warp (Perrakis et al, 1997) was employed to build
the model. Eventually, Arp/warp built half the model, and the rest
of the model was built manually using the programs O (Jones et al,
1991) and COOT (Emsley and Cowtan, 2004). Structure reﬁnement
was performed with REFMAC5 (Murshudov et al, 1997) and CNS.
After the 2.6-A ˚ model was built, the native data set was used to
reﬁne the structure to 2.1A ˚ using CNS. The twinning fraction was
found to be 0.49 using CNS. The crystal was treated as a perfect
twin, and the data accordingly detwinned using CNS. The atomic
coordinates of the FIR1þ2:H25 complex have been deposited with
the Brookhaven Protein Data Bank (PDB code 2QFJ).
ClustalW (Thompson et al, 1994) was used for the sequence
alignment among FIR1þ2, sex-lethal and HuD. The alignment
found by the program was compared to structural overlays of sex-
lethal and FIR1þ2, and, accordingly, slight modiﬁcations to the
alignment were manually performed in the region linking the two
RRM domains to reﬂect the true structural alignment of those
residues. Structural overlays were performed using LSQKAB
(Kabsch, 1976) in the CCP4 software package.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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